Royalty Pharma Q3 Adj. EPS $1.21 Beats $1.18 Estimate, Sales $690.000M Miss $796.528M Estimate
Benzinga Newsdesk 16 hours ago
NewsEarningsEarnings BeatsEarnings Misses
Royalty Pharma (NASDAQ:RPRX) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $1.18 by 2.54 percent. This is a 3.42 percent increase over earnings of $1.17 per share from the
Royalty Pharma (NASDAQ:RPRX) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $1.18 by 2.54 percent. This is a 3.42 percent increase over earnings of $1.17 per share from the same period last year. The company reported quarterly sales of $690.000 million which missed the analyst consensus estimate of $796.528 million by 13.37 percent. This is a 13.30 percent increase over sales of $609.000 million the same period last year.